Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Omnifit Hydroxylapatite (HA) Hip Outcomes Study

NCT00958347 is registered in ClinicalTrials.gov with Stryker Orthopaedics as lead sponsor.

NCT NCT00958347
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00958347 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Omnifit Hydroxylapatite (HA) Hip Outcomes Study
Lead sponsor
Stryker Orthopaedics
Phase
Not applicable
Overall status
Terminated
Start date
October 31, 1987
Completion date
May 31, 2011
Enrollment
226 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

arthroplasty, replacement, hip